Dr Reddy’s Laboratories has received first cycle new drug application (NDA) approval, from the US health regulator, for its Impoyz cream used for treating psoriasis.

Impoyz Cream is a high potency topical steroid, approved for the treatment of moderate to severe plaque psoriasis in patients of 18 years of age or older.

As per Dr Reddy’s Laboratories, “The company through its wholly owned subsidiary Promius Pharma, LLC, has received its fifth consecutive, first-cycle NDA approval from the US Food and Drug Administration (USFDA) for the Proprietary Products Group.”

Read EquityPandit’s Technical Analysis on Nifty Pharma